Journals / Endokrinolojide Diyalog Dergisi / 2011 / Cilt: 8 - Sayı: 1

Our completion thyroidectomy experience

Tamamlayıcı tiroidektomi deneyimimiz

Pages
4–6
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Completion thyroidectomy can be performed safely in experienced centers.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of this study was to compare the frequency of postoperative complications in patients who underwent primary total thyroidectomy and those who underwent completion thyroidectomy due to malignant, benign cancer or to recurrent disease.
📊
Key Findings & Data:Materials and methods: We reviewed the medical records of patients who underwent total thyroidectomy and completion thyroidectomy between the years 2002 and 2008.
💡
Conclusion & Impact:Completion thyroidectomy can be performed safely in experienced centers.
🔬Design:Review & Systematic Survey
📍Scope:2002 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: The aim of this study was to compare the frequency of postoperative complications in patients who underwent primary total thyroidectomy and those who underwent completion thyroidectomy due to malignant, benign cancer or to recurrent disease. Materials and methods: We reviewed the medical records of patients who underwent total thyroidectomy and completion thyroidectomy between the years 2002 and 2008. We divided the patients into three groups as the completion thyroidectomy performed cases (group 1), total thyroidectomy performed cases due to recurrent disease (group 2) and primary total thyroidectomy performed cases due to benign or malignant disease (group 3). The results were analyzed according to postoperative complications in the groups. Results: The number of patients operated on due to thyroid diseases was 1186. We performed completion thyroidectomy in 51 patients with malignant disease, total thyroidectomy in 38 patients with recurrent benign disease and 211 patients with primary benign or malignant disease. There were no differences between the groups with regard to temporary hypocalcemia, dysphonia, or permanent loss of voice (p>0.05). On the other hand, frequency of permanent hypocalcemia was smaller in group 1 as compared to the other groups (p=0.039, p=0.022). Conclusion: Frequency of postoperative complications in completion thyroidectomy is not higher than that encountered in primary or secondary total thyroidectomy performed patients. Completion thyroidectomy can be performed safely in experienced centers.

Özet

Amaç: Tamamlayıcı tiroidektomi yaptığımız olgularla, nüks tiroid hastalığı nedeni ya da benign veya malign tiroid hastalığı tanısı ile primer olarak total tiroidektomi uyguladığımız olguların postoperatif komplikasyonlar açısından karşılaştırılması. Gereç ve yöntem: 2002-2008 yılları arasında kliniğimizde nüks, benign ya da malign tiroid hastalığı nedeni ile total tiroidektomi veya malign hastalık nedeni ile tamamlayıcı tiroidektomi uygulanan olgular retrospektif olarak incelendi. Olgular tamamlayıcı tiroidektomi uygulananlar (grup 1), nüks hastalık nedeni ile total tiroidektomi uygulananlar (grup 2) ve benign veya malign hastalık nedeni ile primer total tiroidektomi uygulananlar (grup 3) olarak üç gruba ayrıldı. Ameliyat sonrasında gelişen komplikasyonların gruplar arasındaki dağılımı incelendi. Bulgular: Tiroid hastalığı nedeni ile ameliyat edilen hastaların sayısı 1186, tamamlayıcı tiroidektomi uygulananlar 51, nüks hastalık nedeni ile total tiroidektomi uygulananlar 38 ve benign veya malign hastalık nedeni ile total tiroidektomi uygulananların sayısı 211 idi. Gruplar arasında ameliyat sonrasında gelişen geçici hipokalsemi, disfoni ve kalıcı ses kısıklığı oranlarında fark saptanmazken (p>0.05); kalıcı hipokalsemi oranı grup 1’de diğer gruplardan daha düşüktü (p=0.039, p=0.022). Sonuç: Ameliyat sonrası gelişen komplikasyon oranının tamamlayıcı tiroidektomi uygulananlarda nüks tiroid hastalığı nedeni ile total tiroidektomi uygulanan veya primer total tiroidektomi uygulananlardan yüksek olmadığı ve tamamlayıcı tiroidektominin deneyimli merkezlerde rahatlıkla yapılabileceği kanaatindeyiz.

🔖

Cite This Article

KAPTANOĞLU, L., UZUN, H., GÖKÇEİMAM, M., TUTAL, F., ESER, M., KURT, N., KÜÇÜK, H. F. (2022). Our completion thyroidectomy experience. Endokrinolojide Diyalog Dergisi, Cilt: 8 - Sayı: 1, 4–6. https://ajindex.com/articles/500764

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Kılıç AY, Sayek İ. Diferansiye tiroid karsinomlarının tedavisinde tamamlayıcı tiroidektominin yeri. In: İşgör A (ed). Tiroid Hastalıkları ve Cerrahisi. İstanbul: Nobel Tıp Kitabevi; 2002, s. 405-409
  2. Sadler GP, Wheeler MH. The thyroid gland. In: Farndon JR (ed). Endocrine Surgery. 2nd edition. Saunders: China 2003 p. 39-87
  3. Pacini F, Elisei R, Capezzone M, et al. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid 2001;11(9):877-881
  4. Kılıç YA, Sayek İ.Tamamlayıcı tiroidektomi. In:Sayek I (ed). Temel cerrahi. Ankara: Güneş kitabevi; 2007. p. 1617-1620
  5. Makay O, Gunalp O, Icoz G, Akyildiz M, Yetkin E. Completion thyroidectomy for thyroid cancer. Acta Chir Belg 2006;106:528-531
  6. El-Zohairy M, Zaher A. Re-operation for the treatment of well differentiated thyroid cancer: necessity, safety and impaction on further management. J Egypt Natl Canc Inst 2004;16(3):130-136
  7. Seiler CA, Glaser C, Wagner HE. Thyroid gland surgery in an endemic region. World J Surg 1996;20:593-596
  8. Chao TC, Jeng LB, Lin JD, Chen MF. Completion thyroidectomy for differantiated thyroid carcinoma. Otolaryngol Head Neck Surg 1998;118:896-899
  9. Machens A, Hinze R, Thomusch O, Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002;26:22-28
  10. Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 2006;140:1007-1008
  11. Kim ES, Kim TY, Koh JM, et al. Completion Thyroidectomy in patients with thyroid cancer who initially undervent unilateral operation. Clinical Endocrinology 2004;61:145-148
  12. Erdem E, Gülçelik MA, Kuru B, Alagöl H. Comparison of completion thyroidectomy and primary surgery for differentiated thyroid carcinoma. Eur J Surg Oncol 2003;29:747-749
  13. Eroğlu A, Berberoğlu U, Buruk F, Yildirim E. Completion thyroidectomy for differentiated thyroid carcinoma. J Surg Onc 1995;59(4):261-267.